<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>9927843</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Elízaga Corrales, J</dc:author>
<dc:description xml:lang="en">Thrombolytic treatment has demonstrated its efficacy on acute myocardial infarction. However, it cannot be used in a significant number of patients and it doesn't achieve adequate reperfusion in a great percentage of cases. Primary angioplasty, a treatment which can be used in the majority of acute myocardial infarction patients, obtains artery patency in more than 90% of cases, with a better perfusion in the infarct territory and fewer reocclusion rates compared to thrombolysis. Consequently, primary angioplasty is associated with a lower mortality rate, and a lower incidence of recurrent ischemia and hemorrhagic stroke during hospitalization. Coronary artery stents and new antiplatelet agents have improved the short-term and mid-term results of primary angioplasty. Currently, when the facilities and trained personal are available, primary angioplasty should be the treatment of choice in acute myocardial infarction.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>1998 Dec </dc:date>
<dc:title xml:lang="es">La angioplastia primaria es la terapéutica de reperfusión de elección en el tratamiento del infarto agudo de miocardio. Argumentos a favor.</dc:title>
<dc:title xml:lang="en">[Primary angioplasty is elective reperfusion therapy in the treatment of acute myocardial infarction. Arguments in favor].</dc:title>
<dc:publisher>Revista espanola de cardiologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
